David MacManus
- Pathology and Forensic Medicine top 0.05%
- Multiple Sclerosis Research Studies 76
- Neurology top 0.2%
- Peripheral Neuropathies and Disorders 16
- Cerebral Venous Sinus Thrombosis 12
- Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research 12
-
- Advanced MRI Techniques and Applications 28
- Advanced Neuroimaging Techniques and Applications 15
- Neurology top 1%
- Peripheral Neuropathies and Disorders 16
- Cerebral Venous Sinus Thrombosis 12
-
- Ultrasound and Hyperthermia Applications 15
-
- Polyomavirus and related diseases 10
- Co-authors
- W. I. McDonaldDavid H. MillerAlan J. ThompsonB. E. KendallI. F. MoseleyD. P. E. KingsleyPaul S. ToftsGareth J. Barker
- Journals
- Neurology (23 papers)Journal of Neurology Neurosurgery & Psychiatry (15 papers)Neuroradiology (11 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
David MacManus
144 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Pathology and Forensic Medicine 6.4k
- Neurology 3.3k
- Rheumatology 1.9k
- Radiology, Nuclear Medicine and Imaging 2.2k
- Neurology 781
Countries citing papers authored by David MacManus
This map shows the geographic impact of David MacManus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David MacManus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David MacManus more than expected).
Fields of papers citing papers by David MacManus
This network shows the impact of papers produced by David MacManus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David MacManus. The network helps show where David MacManus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David MacManus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 14 | |
| 4 | 2020 | 11 | |
| 5 | 2018 | 26 | |
| 6 | Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study biomarker outcome results | 2016 | 1 |
| 7 | Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study results | 2016 | 2 |
| 8 | Effects of BG-12 on magnetic resonance imaging outcomes in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a randomized, placebo-controlled, phase 3 study | 2012 | 3 |
| 9 | Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study | 2012 | 2 |
| 10 | Effects of oral BG-12 (Dimethyl Fumarate) on Magnetic Resonance Imaging (Mri) Outcomes in Relapsing-Remitting Multiple Sclerosis (Rrms): an Integrated Analysis of the Phase 3 Define and Confirm Studies | 2012 | 6 |
| 11 | 2008 | 101 | |
| 12 | The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions | 2008 | 2 |
| 13 | The kinetics of brain atrophy during the first year of treatment with natalizumab | 2007 | 1 |
| 14 | Efficacy of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remitting multiple sclerosis: results of a phase 2 study | 2006 | 13 |
| 15 | BG00012, a novel oral fumarate, is effective in patients with relapsing-remitting multiple sclerosis | 2006 | 11 |
| 16 | 2004 | 85 | |
| 17 | Magnetic resonance spectroscopy of patients with Wilson's disease | 2001 | 1 |
| 18 | 2000 | 36 | |
| 19 | The effect of section thickness on magnetic resonance lesion detection and quantification in multiple sclerosis | 1998 | 5 |
| 20 | 1990 | 219 |
About David MacManus
David MacManus is a scholar working on Pathology and Forensic Medicine, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 146 papers that have together received 10.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (76 papers), Advanced MRI Techniques and Applications (28 papers), Peripheral Neuropathies and Disorders (16 papers), Ultrasound and Hyperthermia Applications (15 papers), Advanced Neuroimaging Techniques and Applications (15 papers), Systemic Lupus Erythematosus Research (12 papers), Cerebral Venous Sinus Thrombosis (12 papers) and Polyomavirus and related diseases (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.4k citations), Neurology (3.3k citations) and Rheumatology (1.9k citations). David MacManus has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include W. I. McDonald, David H. Miller, Alan J. Thompson, B. E. Kendall, I. F. Moseley, D. P. E. Kingsley, Paul S. Tofts, Gareth J. Barker, I. F. Moseley and Allan G. Kermode. Their work appears in journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry, Neuroradiology, Journal of Neurology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.